185 related articles for article (PubMed ID: 15290849)
1. Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Pharm Res; 2004 Jul; 21(7):1109-18. PubMed ID: 15290849
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Gene Ther; 2004 Aug; 11(15):1205-14. PubMed ID: 15103321
[TBL] [Abstract][Full Text] [Related]
3. Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation.
Hosseinkhani H; Kushibiki T; Matsumoto K; Nakamura T; Tabata Y
Cancer Gene Ther; 2006 May; 13(5):479-89. PubMed ID: 16276347
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
[TBL] [Abstract][Full Text] [Related]
6. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
Kasper FK; Kushibiki T; Kimura Y; Mikos AG; Tabata Y
J Control Release; 2005 Oct; 107(3):547-61. PubMed ID: 16139915
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.
Kushibiki T; Tomoshige R; Iwanaga K; Kakemi M; Tabata Y
J Control Release; 2006 May; 112(2):249-56. PubMed ID: 16545479
[TBL] [Abstract][Full Text] [Related]
8. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
[TBL] [Abstract][Full Text] [Related]
9. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Biodegradable Gelatin Nanospheres with a Narrow Size Distribution for Carrier of Cellular Internalization of Plasmid DNA.
Doi N; Jo J; Tabata Y
J Biomater Sci Polym Ed; 2012; 23(8):991-1004. PubMed ID: 21477460
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
[TBL] [Abstract][Full Text] [Related]
12. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
[TBL] [Abstract][Full Text] [Related]
14. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
Lai RX; Yuan SZ; Nakamura T
Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
[TBL] [Abstract][Full Text] [Related]
15. Augmented anti-tumor therapy through natural targetability of macrophages genetically engineered by NK4 plasmid DNA.
Okasora T; Jo JI; Tabata Y
Gene Ther; 2008 Apr; 15(7):524-30. PubMed ID: 18239606
[TBL] [Abstract][Full Text] [Related]
16. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
18. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma.
Matsumoto G; Kushibiki T; Kinoshita Y; Lee U; Omi Y; Kubota E; Tabata Y
Cancer Sci; 2006 Apr; 97(4):313-21. PubMed ID: 16630124
[TBL] [Abstract][Full Text] [Related]
19. Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet.
Manabe T; Mizumoto K; Nagai E; Matsumoto K; Nakamura T; Nukiwa T; Tanaka M; Matsuda T
Clin Cancer Res; 2003 Aug; 9(8):3158-66. PubMed ID: 12912968
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
Biochem Biophys Res Commun; 2007 Jun; 358(1):117-23. PubMed ID: 17467663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
